On the origin of cortical dopamine: Is it a co-transmitter in noradrenergic neurons?

Current Neuropharmacology

Volumn 4, Issue 2, 2006, Pages 115-125

  Devoto, Paola ^a,b   Flore, Giovanna ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b BB Brodie Department of Neuroscience   (Italy)

Author keywords

Antipsychotic; Cerebral cortex; Dopaminergic innervation; Morphine; Noradrenaline (NA); NORADRENERGIC DRUGS

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBACHOL; CLONIDINE; CLOZAPINE; DOPAMINE; HALOPERIDOL; IDAZOXAN; KAINIC ACID; MIANSERIN; MIRTAZAPINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID; NEUROTRANSMITTER; NORADRENALIN; OLANZAPINE; OXIDOPAMINE; QUINPIROLE; VANOXERINE;

ATTENTION DEFICIT DISORDER; BRAIN CORTEX; CEREBELLUM CORTEX; CHEMICAL MODIFICATION; COGNITION; CONCENTRATION (PARAMETERS); DEPRESSION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; DRUG SELECTIVITY; DRUG TARGETING; DRUG WITHDRAWAL; ELECTROSTIMULATION; HUMAN; HYPOTHESIS; INNERVATION; LOCUS CERULEUS; MICRODIALYSIS; NONHUMAN; NORADRENERGIC NERVE; NORADRENERGIC SYSTEM; NUCLEUS ACCUMBENS; OCCIPITAL CORTEX; PARIETAL LOBE; PREFRONTAL CORTEX; PROTEIN TRANSPORT; PSYCHOSIS; RAT; REVIEW; SCHIZOPHRENIA; VENTRAL TEGMENTUM;

EID: 33646576814     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157015906776359559     Document Type: Review

References (132)

1. Acquas, E., Carboni, E., Di Chiara, G. (1991) Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur. J. Pharmacol., 193, 133-134.
2. Aghajanian, G.K. (1978) Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine. Nature, 267, 186-188.
3. Aghajanian, G.K. (1984) In: Usdin E, Carlsson A, Dahlstrom A, Engel J Eds, Catecholamines: neuropharmacology and central nervous system - theoretical aspects. New York, Alan R. Liss pp. 85-92.
4. Aghajanian, G.K. (1985) Modulation of a transient outward current in serotonergic neurons by a1-adrenoceptors. Nature, 315, 501-513.
5. Ahn, N.G., Klinman, J.P. (1989) Nature of rate-limiting steps in a compartmentalized enzyme system. Quantitation of dopamine transport and hydroxylation rates in resealed chromaffin granule ghosts. J. Biol. Chem., 264, 12259-12165.
6. Andén, N.-E., Grabowska, M. (1976) Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur. J. Pharmacol., 39, 275-282.
7. Arnsten, A.F.T. (1997) Catecholamine regulation of the prefrontal cortex. J. Psychopharm., 11, 151-162.
8. Arnsten, A.F.T. (2004) Adrenergic targets for the treatment of cognitive deficit in schizophrenia. Psychopharmacology, 174, 25-31.
9. Bannon, M.J., Michaud, R.L., Roth, R.H. (1981) Mesocortical dopamine neurons. Lack of autoreceptors modulating dopamine synthesis. Mol. Pharmacol., 19, 270-275.
10. Bannon, M.J., Reinhard, J.F. Jr, Bunney, E.B., Roth, R.H. (1982) Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurones. Nature, 296, 444-446.
11. Barton, J. (2005) Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder. Arch. Dis. Child, suppl. 1, i26-i29.
12. Bassareo, V., Tanda G., Petromilli, P., Giua, C., Di Chiara, G. (1996) Non-psychostimulants drugs of abuse activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat. Psychopharmacology, 124, 293-299
13. Breese, G.R., Knapp, D.J., Criswell, H.E., Moy, S.S., Papadeas, S.T., Blake, B.L. (2005) The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. Brain Res. Rev., 48, 57-73.
14. Bymaster, F.P., Calligaro, D.O., Falcone, J.F., Marsh, R.D., Moore, N.A., Tye, N.C., Seeman, P., Wong, D.T. (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology, 14, 87-96.
15. Carboni, E., Tanda, G.L., Frau, R., Di Chiara, G. (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem., 55, 1067-1070.
16. Carr, D.B., Sesack, S.R. (2000) Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci., 20, 3864-3873.
17. Cass, W.A., Gerhardt, G.A. (1995) In Vivo Assessment of Dopamine Uptake in Rat Medial Prefrontal Cortex: Comparison with Dorsal Striatum and Nucleus Accumbens. J. Neurochem., 65, 201-207
18. Castaneda, E., Whishaw, I.Q., Robinson, T.E. (1990) Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J. Neurosci., 10, 1847-1854.
19. Cenci, M.A., Kalen, P., Mandel, R.J., Bjorklund, A. (1992) Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat. Brain Res., 581, 217-228.
20. Chiodo, L.A., Bannon, M.J., Grace, A.A., Roth, R.H., Bunney, B.S. (1984) Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. Neuroscience, 12, 1-16.
21. Ciliax, B.J., Heilman, C., Demchyshyn, L.L., Pristupa, Z.B., Ince, E., Hersch, S.M., Niznik, H.B., Levey, A.I. (1995) The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci., 15, 1714-1723.
22. Darracq, L., Blanc, G., Glowinski, J., Tassin, J.-P. (1998) Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J. Neurosci., 18, 2729-2739.
23. Descarries, L., Lemay, B., Doucet, G., Berger, B. (1987) Regional and laminar density of the dopamine innervation in adult rat cerebral cortex. Neuroscience, 21, 807-824.
24. Devoto, P., Flore, G., Pani, L., Gessa, G.L. (2001) Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex. Mol. Psychiatry, 6, 657-664.
25. Devoto, P., Flore, G., Pira, L., Diana, M., Gessa, G.L. (2002) Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal. Psychopharmacology, 160, 220-224.
26. Devoto, P., Flore, G., Longu, G., Pira, L., Gessa, G.L. (2003) Origin of extracellular dopamine from dopamine and noradrenaline neurons in the medial prefrontal and occipital cortex. Synapse, 50, 200-205.
27. Devoto, P., Flore, G., Vacca, G., Pira, L., Area, A., Casu, M.A., Pani, L., Gessa, G.L. (2003) Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. Psychopharmacol., 167, 79-84.
28. 2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex. J. Neurochem., 88, 1003-1009.
29. Devoto, P., Flore, G., Pira, L., Longu, G., Gessa, G.L. (2004) Mirtazapine-induced co-release of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Eur. J. Pharmacol., 487, 105-111.
30. Devoto, P., Flore, G., Saba, P., Fà, M., Gessa, G.L. (2005) Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus. BMC Neuroscience, 6, 31. http://www.biomedcentral.com/1471-2202/6/31.
31. Devoto, P., Flore, G., Saba, P., Fà, M., Gessa, G.L. (2005) Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex. J. Neurochem., 92, 368-374
32. Devoto, P., Flore, G., Saba, P., Gessa, G.L. (2005) Co-release of dopamine and noradrenaline in the rat cerebral cortex: evidence from 6-hydroxy-dopamine VTA lesion. Washington DC: Society for Neuroscience, Abstract Viewer/Itinerary Planner, Program No 605.3.
33. Diana, M., Pistis, M., Muntoni, A.L., Gessa, G.L. (1995) Profound decrease of mesolimbic dopaminergic neuronal activity in morphine withdrawn rats. J. Pharm. Exp. Ther., 272, 781-785
34. Dong, Y., Cooper, D., Nasif, F., Hu, X.-T., White, F.J. (2004) Dopamine modulates inwardly rectifying potassium currents in medial prefrontal cortex pyramidal neurons. J. Neurosci., 24, 3077-3085.
35. Fadda, F., Gessa, G.L., Marcou, M., Mosca, E., Rossetti, Z. (1984) Evidence for dopamine autoreceptors in mesocortical dopamine neurons. Brain Res., 293, 67-72.
36. Feenstra, M.G.P. (2000) Dopamine and noradrenaline release in the prefrontal cortex in relation to unconditioned and conditioned stress and reward. Progr. Brain Res., 126, 133-163.
37. Finlay, J.M., Zigmond, M.J., Abercrombie, E.D. (1995) Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience, 64, 619-628.
38. Florin-Lechner, S.M., Druhan, J.P., Aston-Jones, G., Valentino, R.J. (1996) Enhanced norepinephrine release in the prefrontal cortex with burst stimulation of the locus coeruleus. Brain Res., 742, 89-97.
39. Friedman, J.I., Adler, D.N., Davis, K.L. (1999) The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease. Biol. Psychiatry, 46, 1243-1252.
40. Galloway, M.P., Wolf, M.E., Roth, R.H. (1986) Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. J. Pharmacol. Exp. Ther., 236, 689-698.
41. Gao, W.J., Wang, Y., Goldman-Rakic, P. (2003) Dopamine modulation of perisomatic and peridendritic inhibition in prefrontal cortex. J. Neurosci., 23, 1622-1630.
42. Gardner, E.L., Ashby, C.R. Jr. (2000) Heterogeneity of the mesotelencephalic dopamine fibers: physiology and pharmacology. Neurosci. Biobehav. Rev., 24, 115-118.
43. Garris, P.A., Collins, L.B., Jones, S.R., Wightman, R.M. (1993) Evoked extracellular dopamine in vivo in the medial prefrontal cortex. J. Neurochem., 61, 637-647.
44. Gessa, G.L., Devoto, P., Diana, M., Flore, G., Melis, M., Pistis, M. (2000) Dissociation of haloperidol, clozapine and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacol., 22, 642-649.
45. 2 receptors in hippocampus and parahippocampal cortex of rat, cat and human in relation to tyrosine hydroxylase-immunoreactive fibers. Hippocampus, 4, 354-373.
46. Gonon, F.G. (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience, 24, 19-28.
47. 1 dopaminergic receptor agents into rat prefrontal cortex. J. Neurosci., 20, 1208-1215.
48. Grenhoff, J., Nisell, M., Ferré, S., Aston-Jones, G., Svensson, T.H. (1993) Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J. Neural. Transm., 93, 11-25.
49. Grenhoff, J., Svensson, T.H. (1989) Clonidine modulates dopamine cell firing in the ventral tegmental area. Eur. J. Pharmacol., 165, 11-18.
50. Gresch, P.J., Sved, A.F., Zigmond, M.J., Finlay, J.M. (1995) Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J. Neurochem., 65, 111-116.
51. Gronier, B., Perry, K.W., Rasmussen, K. (2000) Activation of the mesocorticolimbic dopaminergic system by stimulation of muscarinic cholinergic receptors in the ventral tegmental area. Psychopharmacol., 147, 347-355
52. Happe, H.K., Coulter, C.L., Gerety, M.E., Sanders, J.D., O'Rourke, M., Bylund, D.B., Murrin, L.C. (2004) Alpha-2 adrenergic receptor development in rat CNS: an autoradiographic study. Neuroscience, 123, 167-178.
53. Harik, S.I., Duckrow, R.B., LaManna, J.C., Rosenthal, M., Sharma, V.K., Banerjee, S.P. (1981) Cerebral compensation for chronic noradrenergic denervation induced by locus coeruleus lesion: recovery of receptor binding, isoproterenol-induced adenylate cyclase activity, and oxidative metabolism. J. Neurosci., 1, 641-649.
54. Harik, S.I. (1984) Locus coeruleus lesion by local 6-hydroxydopamine infusion causes marked and specific destruction of noradrenergic neurons, long-term depletion of norepinephrine and the enzymes that synthesize it, and enhanced dopaminergic mechanisms in the ipsilateral cerebral cortex. J. Neurosci., 4, 699-707.
55. Heidbreder, C.A., Foxton, R., Cilia, J., Hughes, Z.A., Shah, A.J., Atkins, A., Hunter, A.J., Hagan, J.J., Jones, D.N.C. (2001) Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation. Psychapharmacology, 156, 338-351.
56. Herrmann, N., Lanctot, K.L., Khan, L.R. (2004) The role of norepinephrine in the behavioral and psychological symptoms of dementia. J. Neuropsychiatry Clin. Neurosci., 16, 261-276.
57. Hertel, P., Nomikos, G.G., Svensson, T.H. (1999) Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level. Eur. J. Pharmacol., 371, 153-158.
58. Horn, A.S. (1973) Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenergic and dopaminergic neurons in rat brain homogenates. Br. J. Pharmacol., 47, 332-338.
59. 2A-adrenoceptors in the mouse prefrontal cortex. Eur. J. Neurosci., 15, 1789-1794.
60. Imperato, A., Di Chiara, G. (1985) Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J. Neurosci., 5, 297-306.
61. Kawahara, Y., Kawahara, H., Westerink, B.H.C. (1999) Comparison of the effects of hypotension and handling stress on the release of noradrenaline and dopamine in the locus coeruleus and medial prefrontal cortex of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 360, 42-49.
62. Kawahara, H., Kawahara, Y., Westerink, B.H.C. (2001) The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis. Eur. J. Pharmacol., 418, 177-186.
63. Kuroki, T., Meltzer, H.Y., Ichikawa, J. (1999) Effect of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J. Pharm. Exp. Ther., 288, 774-781.
64. Lapiz, M.D., Morilak, D.A. (2006) Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional shifting capability. Neuroscience, 137, 1039-1049.
65. Le Moal, M., Simon, H. (1991) Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol. Rev., 71, 155-234.
66. Li, X.-M., Perry, K.W., Wong, D.T., Bymaster, F.P. (1998) Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum. Psychopharmacol., 136, 153-161.
67. 3H]raclopride. Proc. Nat. Acad. Sci. USA, 86, 6412-6416.
68. Lidow, M.S., Williams, G.V., Goldman-Rakic, P.S. (1998) The cerebral cortex: a case for a common site of action of antipsychotics. Trends Pharmacol. Sci., 19, 136-140
69. Lindvall, O., Björklund, A., Divac, I. (1978) Organization of the catecholamine neurons projecting to the frontal cortex in the rat. Brain Res., 142, 1-24.
70. Logan, L.J., Harik, S.I. (1982) Specific uptake of norepinephrine and dopamine by homogenates of rat cerebral cortex after locus coeruleus lesion. J. Neurosci., 2, 394-398.
71. 125I]iodosulpiride, a highly selective ligand. Science, 228, 752-755.
72. Masi, G. (2005) Pharmacotherapy of pervasive developmental disorders in children and adolescents. CNS Drugs, 18, 1031-1052.
73. Mattay, V.S., Goldberg, T.E., Fera, F., Hariri, A.R., Tessitore, A., Egan, M.F., Kolachana, B., Callicott, J.H., Weinberger, D.R. (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc. Nat. Acad. Sci. USA, 100, 6186-6191.
74. Matthews, R.T., German, D.C. (1984) Electrophysiological evidence for excitation of rat ventral tegmental area dopaminergic neurons by morphine. Neuroscience, 11, 617-625.
75. Meltzer, H.Y. (1994) An overview of the mechanism of action of clozapine. J. Clin. Psychiatry, 55, 47-52.
76. c receptors: A comparison with citalopram. Eur. J. Neurosci., 12, 1079-1095.
77. Miner, L.H., Schroeter, S., Blakely, R.D., Sesack, S.R. (2000) Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals. J. Comp. Neurol., 427, 220-234.
78. Miner, L.H., Schroeter, S., Blakely, R.D., Sesack, S.R. (2003) Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals. J. Comp. Neurol., 466, 478-494.
79. Moghaddam, B., Bunney, B.S. (1990) Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J. Neurochem., 54, 1755-1760
80. Moron, J.A., Brockington, A., Wise, R.A., Rocha, B.A., Hope, B.T. (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J. Neurosci., 22, 389-395.
81. Mundorf, M.L., Joseph, J.D., Austin, C.M., Caron, M.G., Wightman, R.M. (2001) Catecholamine release and uptake in the mouse prefrontal cortex. J. Neurochem., 79, 130-142.
82. Murphy, B.L., Arnsten, A.F., Goldman-Rakic, P.S., Roth, R.H. (1996) Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl. Acad. Sci. USA, 93, 1325-1329.
83. Murphy, E.K., Sved, A.F., Finlay, J.M. (2003) Corticotropin-releasing hormone receptor blockade fails to alter stress-evoked catecholamine release in prefrontal cortex of control or chronically stressed rats. Neuroscience, 116, 1081-1087.
84. Nomikos, G.G., Iurlo, M., Andersson, J.L., Kimura, K., Svensson, T.H. (1994) Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Psychopharmacology, 115, 147-156.
85. Oades, R.D., Sadile, G.A., Sagvolden, T., Viggiano, D., Zuddas, A., Devoto, P., Aase, H., Johansen, E.B., Ruocco, L.A., Russel, V.A. (2005) The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles. Develop. Sci., 8, 122-131.
86. Onn, S.-P., Wang, X.-B. (2005) Differential modulation of anterior cingulate cortical activity by afferents from ventral tegmental area and mediodorsal thalamus. Eur. J. Neurosci., 21, 2975-2992.
87. Paladini, C.A., Williams, J.T. (2004) Noradrenergic inhibition of midbrain dopamine neurons. J. Neurosci., 24, 4568-4575.
88. Pan, W.H., Sung, J.C., Fuh, S.M. (1996) Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission. J. Pharmacol. Exp. Ther., 278, 725-731.
89. Paxinos, G., Watson, C. (1997) The rat brain in stereotaxic coordinates. 3rd Edition, Academic Press, San Diego, California.
90. Pehek, E.A., Yamamoto, B.K. (1994) Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J. Neurochem. 63, 2118-2124.
91. Pira, L., Mongeau, R., Pani, L. (2004) The atypical antipsychotic quetiapine increases both noradrenaline and dopamine release in the rat prefrontal cortex. Eur. J. Pharmacol., 504, 61-64
92. Pothos, E., Rada, P., Mark, G.P., Hoebel, B.G. (1991) Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res., 566, 348-350.
93. Pozzi, L., Invernizzi, R., Cervo, L., Vallebuona, F., Samanin, R. (1994) Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J. Neurochem., 63, 195-200.
94. Pucak, M.L., Grace, A.A. (1994) Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. J. Pharmacol. Exp. Ther., 271, 1181-1192.
95. Raiteri, M., Del Carmine, R., Bertollini, A., Levi, G. (1977) Effects of sympaticomimetic amines on the synaptosomal transport of noradrenaline, dopamine,5-hydroxytryptamine. Eur. J. Pharmacol., 41, 133-143.
96. Ramirez, O.A., Wang, R.Y. (1986) Locus coeruleus norepinephrine-containing neurons: effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine. Brain Res., 362, 165-170.
97. 2 receptors in the cerebral cortex of rats, cats and monkeys. J. Comp. Neurol., 286, 409-426.
98. Roberts, D.C., Zis, A.P., Fibiger, H.C. (1975) Ascending catecholamine pathways and amphetamine-induced locomotor activity: importance of dopamine and apparent non-involvement of norepinephrine. Brain Res., 93, 441-454.
99. Robinson, T.E., Whishaw, I.Q. (1988) Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res., 450, 209-224.
100. Rossetti, Z.L., Longu, G., Mercuro, G., Gessa, G.L. (1993) Extraneuronal noradrenaline in the prefrontal cortex of morphine-dependent rats: tolerance and withdrawal mechanisms. Brain Res., 609, 316-320.
101. Rozza, A., Masoero, E., Favalli, L., Lanza, E., Govoni, S., Rizzo, V., Montalbetti, L. (2000) Influence of different anaesthetics on extracellular aminoacids in rat brain. J. Neurosci. Methods, 101, 165-169.
102. Sachs, C., Johnsson, G. (1975) Mechanism of action of 6-hydroxydopamine. Biochem. Pharmacol., 24, 1-8.
103. Sanders, J.D., Happe, H.K., Bylund, D.B., Murrin, L.C. (2005) Development of the norepinephrine transporter in the rat CNS. Neuroscience, 130, 107-117.
104. 2-adrenergic receptor subtype gene expression in rat brain. Mol. Brain Res., 21, 133-149.
105. Seamans, J.K., Yang, C.R. (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog. Neurobiol., 74, 1-57.
106. Seguela, P., Watkins, K.C., Geffard, M., Descarries, L. (1990) Noradrenaline axon terminals in adult rat neocortex: an immunohistochemical analysis in serial thin sections. Neuroscience, 35, 249-264.
107. Sesak, S.R., Hawrylak, V.A., Matus, C., Guido, M.A., Levey, A.I. (1998) Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J. Neurosci., 18, 2696-2708.
108. Shimada, S., Kitayama, S., Walther, D., Uhl, G. (1992) Dopamine transporter mRNA: Dense expression in ventral midbrain neurons. Mol. Brain Res., 13, 359-362
109. Silverstone, P.H., Done, C., Sharp, T. (1992) Clonidine but not nifedipine prevents the release of noradrenaline during naloxone-precipitated opiate withdrawal: an in vivo microdialysis study in the rat. Psychopharmacology, 109, 235-238.
110. Soares da Silva, P., Garrett, M.C. (1990) A kinetic study of the rate of formation of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the brain of the rat: implications for the origin of DOPAC. Neuropharmacology, 29, 869-874.
111. Souto, M., Monti, J.M., Altier, H. (1979) Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons. Pharmacol. Biochem. Behav., 10, 5-9.
112. 2-adrenoceptor antagonist idazoxan against 6-hydroxy-dopamine-induced Parkinsonism in rats: multiple facets of action? Naunyn-Schmiedeberg's Arch. Pharmacol., 369, 629-638.
113. Swanson, L.W. (1982) The projection of the ventral tegmental area and adjacent areas: a combined retrograder tracer and immunofluorescence study of the rat. Brain Res. Bull., 9, 321-353.
114. Tanda, G., Bassareo, V., Di Chiara, G. (1996) Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat. Psychopharmacol., 123, 127-130.
115. Tanda, G., Pontieri, F.E., Frau, R., Di Chiara, G. (1997) Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur. J. Neurosci., 9, 2077-2085.
116. Tassin, J.P., Lavielle, S., Hervé, D., Blanc, G., Thierry, A.M., Alvarez, C., Berger, B., Glowinski, J. (1979) Collateral sprouting and reduced activity of the rat mesocortical dopaminergic neurons after selective destruction of the ascending noradrenergic bundle. Neuroscience, 4, 1569-1582.
117. 2 agonist binding sites in the rat and human central nervous system: analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res., 319, 69-101.
118. Valentini, V., Frau, R., Di Chiara, G. (2004) Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine. J. Neurochem., 88, 917-927.
119. Vizi, E.S., Zsilla, G., Caron, M.G., Kiss, J.P. (2004) Uptake and release of norepinephrine by serotonergic terminals in norepinephrine transporter knock-out mice: implications for the action of selective serotonin reuptake inhibitors. J. Neurosci., 24, 7888-7894.
120. Volonte, M., Monferini, E., Cerutti, M., Fodritto, F., Borsini, F. (1997) BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex. J. Neurochem., 69, 182-190.
121. 4 recetros in the rat brain - Immunocytochemical study. J. Physiol. Pharmacol., 51, 205-221.
122. Westerink, B.H. C., Enrico, P., Feimann, J., De Vries, J.B. (1998) The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain. J. Pharmacol. Exp. Ther., 285, 143-154.
123. Westerink, B.H.C., de Boer, P., de Vries, J.B., Kruse, C.G., Long, S.K. (1998) Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain. Eur. J. Pharmacol., 361, 27-33
124. Westerink, B.H., Kawahara, Y., De Boer, P., Geels, C., De Vries, J.B., Wikstrom, H.V., Van Kalkeren, A., Van Vliet, B., Kruse, C.G., Long, S.K. (2001) Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum. Eur. J. Pharmacol., 412, 127-138.
125. 1 receptors in prefrontal cortex. Nature, 376, 572-575.
126. Winterer, G., Weinberger, D.R. (2004) Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci., 27, 683-690.
127. Yamamoto, B.K., Novotney, S. (1998) Regulation of extracellular dopamine by the norepinephrine transporter. J. Neurochem., 71, 274-280.
128. Yamamoto, K., Hornykiewicz, O. (2004) Proposal for a noradrenaline hypothesis of schizophrenia. Progr. Neuro-Psychopharm. Biol. Psy., 28, 913-922.
129. 2-adrenergic control of dopamine overflow and metabolism in mouse striatum. Eur. J. Pharmacol., 339, 113-119.
130. Zetterstrom, T., Sharp, T., Collin, A.K., Ungerstedt, U. (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol., 148, 327-334.
131. Zigmond, M.J., Abercrombie, E.D., Berger, T.W., Grace, A.A., Stricker, E.M. (1990) Compensation after lesion of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci., 13, 290-296.
132. Zoli, M., Jansson, A., Sykovà, E., Agnati, L.F., Fuxe, K. (1999) Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol. Sci., 20, 142-150.